Rabbit anti-Aladin Antibody Affinity Purified
Product Details
Specifications
The epitope recognized by A304-514A maps to a region between residue 496 to 546 of human adrenocortical Insufficiency using the numbering given in entry NP_056480.1 (GeneID 8086).
Immunoglobulin concentration was determined using Beer’s Law where 1mg/mL IgG has an A280 of 1.4. Antibody was affinity purified using an epitope specific to Aladin immobilized on solid support.
The epitope recognized by A304-514A-T maps to a region between residue 496 to 546 of human adrenocortical Insufficiency using the numbering given in entry NP_056480.1 (GeneID 8086).
Additional Product Information
Aladin is a member of the WD-repeat family of regulatory proteins and may be involved in normal development of the peripheral and central nervous system. Aladin is part of the nuclear pore complex and is anchored there by NDC1. Defects in the coding gene are a cause of achalasia-addisonianism-alacrima syndrome (AAAS), also called triple-A syndrome or Allgrove syndrome [taken from NCBI Entrez Gene (Gene ID: 8086)].
Alternate Names
AAA; AAASb; achalasia, adrenocortical insufficiency, alacrimia; ADRACALA; ADRACALIN; ALADIN; Allgrove, triple-A; GL003
Applications
All western blot analysis is performed using 5% Milk-TBST for blocking and as antibody diluent. Primary antibody is incubated overnight.
Western blots of cell lysates are performed using Goat anti-Rabbit IgG Heavy and Light Chain Antibody (Cat. No. A120-101P).
Western blots of immunoprecipitates are performed using Goat anti-Rabbit Light Chain HRP Conjugate (Cat. No. A120-113P) with 5% Normal Pig Serum (Cat. No. S100-020) added to the blocking buffer.